Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no cheaper alternative version of Mounjaro itself — tirzepatide is a single branded medicine made by Eli Lilly, and no generic exists in the UK. What does vary significantly is the total private cost of accessing it: prices across providers range from roughly £149 to £375 per month depending on dose and what the clinic or pharmacy includes. These are prescription-only medicines, so any legitimate route to them requires a clinical assessment by a qualified prescriber. The price you see advertised and the price you actually pay are not always the same thing — and understanding that gap is where most people save themselves a nasty surprise.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the moment: you've typed the dose into a search engine, spotted something noticeably cheaper than everywhere else, and you're hovering over a button. That feeling is understandable. Mounjaro is not inexpensive, and finding what looks like a deal feels like a relief.
Here's the honest picture. Eli Lilly raised the UK list price for Mounjaro substantially from 1 September 2025, the highest-dose pen's list price moved from around £122 to around £330. Private clinic and pharmacy prices since then have typically sat between roughly £149 and £375 per month by dose and provider, as widely reported at the time. Those figures are real. They are also, in most cases, the floor, not a guaranteed ceiling.
A common misconception is that a low headline figure means the overall cost is lower. Often it just means more things have been separated out. Consultation fees, prescription charges, delivery costs and any kind of clinical follow-up are all real costs that have to land somewhere. Some providers absorb them into one figure. Others do not. Reading what is actually included before comparing prices takes about three minutes and can easily save you more than any apparent discount would. The full breakdown of what drives Mounjaro pricing in the UK is worth reviewing alongside any quote you receive.
Mounjaro is a Prescription-Only Medicine. Under UK law, that means a registered prescriber must assess you and issue a prescription before a pharmacy can dispense it. That clinical step is not optional, and its cost does not disappear, it either sits inside the price you are quoted or it is billed separately.
A genuinely all-in price covers: the consultation (including identity verification and weight confirmation); the prescription itself; the medicine from a verifiable UK supply chain; and delivery. If aftercare (clinical support between orders, dose-review guidance, access to a prescriber when something changes) is also included, that has real value too.
At nume, one transparent price covers all of that. We are not the cheapest option on the market, and that is a deliberate choice: what that price buys is a consultation personally reviewed by a named, GPhC-registered Independent Prescriber the same day you submit it, medicine dispensed by our own registered pharmacy, and free next-working-day delivery by DPD. There are no subscription commitments and no auto-renewals; every repeat order goes through clinical review again. You can see exactly what is offered on our treatment page.
For context on how the overall costs compare across routes, including NHS access, the Mounjaro overview sets out the fuller picture.
The MHRA has warned publicly and repeatedly about fake weight-loss pens sold through social media and unverified websites. In 2025 alone, enforcement operations seized around 20 million doses of illegally traded weight-loss medicines (a street value of roughly £45 million), and a site in Northampton manufacturing counterfeit tirzepatide pens was raided. Some fake pens seized in earlier operations contained insulin rather than the labelled medicine, a genuinely dangerous substitution. The MHRA's Yellow Card scheme allows anyone to report a suspect seller, and the regulator's guidance on GLP-1 medicines is clear that these products should only be obtained through a clinical pathway.
The markers of an unsafe source are consistent: medicines offered without a prescription, prices far below the market range, no verifiable UK pharmacy registration. You can check any online pharmacy in seconds on the GPhC pharmacy register, our registration number is 9012878 if you want to verify us directly. A small saving is not the measure that keeps you safe; what you are actually injecting is.
For those wondering whether Mounjaro prices are likely to fall over time, the picture on future pricing is worth reading too, it covers the factors that could shift costs in either direction. If you have come across unusually low quotes and want to understand why Mounjaro sometimes appears cheaper in the UK than you might expect, that context is useful before drawing any conclusions. And if you want specific guidance on finding a more cost-effective legitimate route, practical options for reducing what you pay are set out clearly there, including whether a cheaper version of Mounjaro is something you can legitimately access.
If you are clinically suitable, the most straightforward next step is a free consultation. A real prescriber reviews it; you find out where you stand.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.